Literature DB >> 35230685

Computational Approaches for the Investigation of Intra-tumor Heterogeneity and Clonal Evolution from Bulk Sequencing Data in Precision Oncology Applications.

Alessandro Laganà1.   

Abstract

While the clonal model of cancer evolution was first proposed over 40 years ago, only recently next-generation sequencing has allowed a more precise and quantitative assessment of tumor clonal and subclonal landscape. Consequently, a plethora of computational approaches and tools have been developed to analyze this data with the goal of inferring the clonal landscape of a tumor and characterize its temporal or spatial evolution. This chapter introduces intra-tumor heterogeneity (ITH) in the context of precision oncology applications and provides an overview of the basic concepts, algorithms, and tools for the dissection, analysis, and visualization of ITH from bulk DNA sequencing.
© 2022. Springer Nature Switzerland AG.

Entities:  

Keywords:  Cancer; Clonal expansion; Clonality; Clone; DNA sequencing; ITH; NGS; Subclone; Tumor; Tumor evolution; Tumor phylogeny

Mesh:

Year:  2022        PMID: 35230685     DOI: 10.1007/978-3-030-91836-1_6

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


  53 in total

1.  Evolution and impact of subclonal mutations in chronic lymphocytic leukemia.

Authors:  Dan A Landau; Scott L Carter; Petar Stojanov; Aaron McKenna; Kristen Stevenson; Michael S Lawrence; Carrie Sougnez; Chip Stewart; Andrey Sivachenko; Lili Wang; Youzhong Wan; Wandi Zhang; Sachet A Shukla; Alexander Vartanov; Stacey M Fernandes; Gordon Saksena; Kristian Cibulskis; Bethany Tesar; Stacey Gabriel; Nir Hacohen; Matthew Meyerson; Eric S Lander; Donna Neuberg; Jennifer R Brown; Gad Getz; Catherine J Wu
Journal:  Cell       Date:  2013-02-14       Impact factor: 41.582

2.  Clonal competition with alternating dominance in multiple myeloma.

Authors:  Jonathan J Keats; Marta Chesi; Jan B Egan; Victoria M Garbitt; Stephen E Palmer; Esteban Braggio; Scott Van Wier; Patrick R Blackburn; Angela S Baker; Angela Dispenzieri; Shaji Kumar; S Vincent Rajkumar; John D Carpten; Michael Barrett; Rafael Fonseca; A Keith Stewart; P Leif Bergsagel
Journal:  Blood       Date:  2012-04-12       Impact factor: 22.113

3.  Integrative network analysis identifies novel drivers of pathogenesis and progression in newly diagnosed multiple myeloma.

Authors:  A Laganà; D Perumal; D Melnekoff; B Readhead; B A Kidd; V Leshchenko; P-Y Kuo; J Keats; M DeRome; J Yesil; D Auclair; S Lonial; A Chari; H J Cho; B Barlogie; S Jagannath; J T Dudley; S Parekh
Journal:  Leukemia       Date:  2017-06-23       Impact factor: 11.528

4.  TGFα and amphiregulin paracrine network promotes resistance to EGFR blockade in colorectal cancer cells.

Authors:  Sebastijan Hobor; Beth O Van Emburgh; Emily Crowley; Sandra Misale; Federica Di Nicolantonio; Alberto Bardelli
Journal:  Clin Cancer Res       Date:  2014-06-10       Impact factor: 12.531

5.  Four evolutionary trajectories underlie genetic intratumoral variation in childhood cancer.

Authors:  Jenny Karlsson; Anders Valind; Linda Holmquist Mengelbier; Sofia Bredin; Louise Cornmark; Caroline Jansson; Amina Wali; Johan Staaf; Björn Viklund; Ingrid Øra; Anna Börjesson; Torbjörn Backman; Noémie Braekeveldt; Bengt Sandstedt; Niklas Pal; Anders Isaksson; Barbara Gürtl Lackner; Tord Jonson; Daniel Bexell; David Gisselsson
Journal:  Nat Genet       Date:  2018-06-04       Impact factor: 38.330

6.  Intratumor heterogeneity and branched evolution revealed by multiregion sequencing.

Authors:  Marco Gerlinger; Andrew J Rowan; Stuart Horswell; James Larkin; David Endesfelder; Eva Gronroos; Pierre Martinez; Nicholas Matthews; Aengus Stewart; Charles Swanton; M Math; Patrick Tarpey; Ignacio Varela; Benjamin Phillimore; Sharmin Begum; Neil Q McDonald; Adam Butler; David Jones; Keiran Raine; Calli Latimer; Claudio R Santos; Mahrokh Nohadani; Aron C Eklund; Bradley Spencer-Dene; Graham Clark; Lisa Pickering; Gordon Stamp; Martin Gore; Zoltan Szallasi; Julian Downward; P Andrew Futreal
Journal:  N Engl J Med       Date:  2012-03-08       Impact factor: 91.245

7.  Precision oncology- the future of personalized cancer medicine?

Authors:  Ann M Bode; Zigang Dong
Journal:  NPJ Precis Oncol       Date:  2017-03-20

8.  Precision oncology: separating the wheat from the chaff.

Authors:  Jordi Remon; Rodrigo Dienstmann
Journal:  ESMO Open       Date:  2018-10-30

Review 9.  Molecular profiling for precision cancer therapies.

Authors:  Eoghan R Malone; Marc Oliva; Peter J B Sabatini; Tracy L Stockley; Lillian L Siu
Journal:  Genome Med       Date:  2020-01-14       Impact factor: 11.117

10.  Non-cell-autonomous driving of tumour growth supports sub-clonal heterogeneity.

Authors:  Andriy Marusyk; Doris P Tabassum; Philipp M Altrock; Vanessa Almendro; Franziska Michor; Kornelia Polyak
Journal:  Nature       Date:  2014-07-30       Impact factor: 49.962

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.